Healthcare & Life Sciences Industry Updates

Google News – FDA (biotech/pharma) External News

Ascelia Pharma: Update on Orviglance NDA suggests clinical CRL concerns center on image reading - Inderes

news.google.com · 14 Jul 2026

Google News – FDA (biotech/pharma) External News

FDA releases 14 drug rejection letters after 3-month pause - Fierce Biotech

news.google.com · 14 Jul 2026

Google News – FDA (biotech/pharma) External News

FDA's latest onshoring move homes in on streamlined facility registration, foreign plant scrutiny - Fierce Pharma

news.google.com · 14 Jul 2026

Google News – FDA (biotech/pharma) External News

FDA posts new rejection letters days after confirming pause - BioSpace

news.google.com · 14 Jul 2026

Google News – FDA (biotech/pharma) External News

Oncolytics Biotech stock jumps on FDA meeting plans for trial - Investing.com

news.google.com · 14 Jul 2026

Google News – FDA (biotech/pharma) External News

Oncolytics Biotech Shares Climb Ahead of Planned FDA Meeting on REO 033 Trial (ONCY) - Yahoo Finance

news.google.com · 14 Jul 2026

Google News – FDA (biotech/pharma) External News

Oncolytics Biotech® Reports FDA Regulatory Milestone and - GlobeNewswire

news.google.com · 14 Jul 2026

Google News – FDA (biotech/pharma) External News

FDA takes first step toward ‘de facto’ ad ban: What to know - PRWeek

news.google.com · 14 Jul 2026

Google News – FDA (biotech/pharma) External News

FDA proposal to modernize drug manufacturing registration - The Pharma Letter

news.google.com · 14 Jul 2026

Google News – FDA (biotech/pharma) External News

Tris Pharma’s CRL for narcolepsy drug; Agenus abandons Phase 3 CRC trial - Endpoints News

news.google.com · 14 Jul 2026

Google News – FDA (biotech/pharma) External News

Elevar liver cancer combo receives third FDA rejection - The Pharma Letter

news.google.com · 14 Jul 2026

Google News – Clinical Trials External News

UK starts first vaccine trial, eight weeks into Ebola emergency - BBC

news.google.com · 14 Jul 2026

Google News – Clinical Trials External News

CEPI-backed Bundibugyo ebolavirus vaccine trial launched by Oxford Vaccine Group - CEPI

news.google.com · 14 Jul 2026

Google News – Clinical Trials External News

FDA approves clinical testing of CAR T-cell therapy for AAV, other conditions - ANCA Vasculitis News

news.google.com · 14 Jul 2026

Google News – Biopharma External News

Argent Biopharma (ASX: RGT) Falls 15% and Is Down Nearly a Quarter Over the Year: Is the Micro-Cap Biotech Facing a Difficult Path? - Kalkine

news.google.com · 14 Jul 2026

News & Articles

Cancer Is Rarely Caused By One Mistake: Why Healthcare Professionals Must Improve Public Understanding

Beyond AI: Why Human Empathy Will Remain Healthcare's Most Valuable Skill

Why healthcare providers are sidelining employees amid coronavirus pandemic

For adults with prediabetes, lifestyle intervention lowered risk of developing multiple chronic conditions

New Alzheimer’s blood test may tell when symptoms are around the corner

4 takeaways from MDUFA VI draft agreement

J&J wins FDA approval for dual-energy ablation catheter

Physicians’ wearable data use hampered by reimbursement, workflow barriers: survey

Vacancy: National Consultant (NO C) to strengthen maternal and newborn health systems.

Stanford Health Care Tri-Valley launches hospital expansion - Stanford Medicine

HHSC, UT Southwestern Medical Center celebrate opening of new psychiatric hospital in Dallas - UT Southwestern Medical

Hospital and health system leaders participate in Healthcare of Tomorrow Conference - American Hospital Association

HCA Healthcare hospitals earn 26 Press Ganey Human Experience Awards for patient experience - HCA Healthcare Today

CEO Nancy Brown named to Becker’s Hospital Review’s 2026 “Great Leaders in Healthcare” list - www.heart.org

Enhancing healthcare workers’ safety and well-being through a comprehensive qualitative analysis across hospital settings - Nature

Providers race to scale hospital-at-home before reimbursement changes - Modern Healthcare

One or Two Health Systems Controlled the Entire Market for Inpatient Hospital Care in Nearly Half of Metropolitan Areas in 2024 - KFF

How the hospital-at-home program offers alternative care as demand surges - investigatetv.com

Layoffs, closures tracker: Adventist Health cuts 132 jobs - Modern Healthcare

Experts: Cuts to federal student loans could hurt first generation students, healthcare industry - MPR News

Ascelia Pharma: Update on Orviglance NDA suggests clinical CRL concerns center on image reading - Inderes

FDA releases 14 drug rejection letters after 3-month pause - Fierce Biotech

FDA's latest onshoring move homes in on streamlined facility registration, foreign plant scrutiny - Fierce Pharma

FDA posts new rejection letters days after confirming pause - BioSpace

Oncolytics Biotech stock jumps on FDA meeting plans for trial - Investing.com

Oncolytics Biotech Shares Climb Ahead of Planned FDA Meeting on REO 033 Trial (ONCY) - Yahoo Finance

Oncolytics Biotech® Reports FDA Regulatory Milestone and - GlobeNewswire

FDA takes first step toward ‘de facto’ ad ban: What to know - PRWeek

FDA proposal to modernize drug manufacturing registration - The Pharma Letter

Tris Pharma’s CRL for narcolepsy drug; Agenus abandons Phase 3 CRC trial - Endpoints News

Elevar liver cancer combo receives third FDA rejection - The Pharma Letter

UK starts first vaccine trial, eight weeks into Ebola emergency - BBC

CEPI-backed Bundibugyo ebolavirus vaccine trial launched by Oxford Vaccine Group - CEPI

FDA approves clinical testing of CAR T-cell therapy for AAV, other conditions - ANCA Vasculitis News

Argent Biopharma (ASX: RGT) Falls 15% and Is Down Nearly a Quarter Over the Year: Is the Micro-Cap Biotech Facing a Difficult Path? - Kalkine